Other
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Roivant Sciences Cash Provided by (Used in) Investing Activity, Including Discontinued Operation increased by 67.0% to -$1.09B in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 112409.4%, from -$965.00K to -$1.09B.
Analysis
StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2020
Last reportedQ1 2025Aug 11, 2025
How to read this metric
Reflects the overall net movement of cash into or out of the investment portfolio and capital assets.
Detailed definition
The total net cash flow from investing activities, aggregating both continuing and discontinued operations. It provides...
Peer comparison
Standard consolidated cash flow metric across all industries.
Metric ID:
other_net_cash_provided_by_used_in_investing_activitiesHistorical Data
12 periods
| Q1 '21 | Q2 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q1 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$2.34M | $317.41M | -$7.46M | -$146.85M | -$3.51M | $105.00K | -$36.45M | $5.23B | $6.93M | -$965.00K | -$3.29B | -$1.09B |
| QoQ Change | — | >999% | -102.3% | <-999% | +97.6% | +103.0% | <-999% | >999% | -99.9% | -113.9% | <-999% | +67.0% |
| YoY Change | — | — | -218.9% | -146.3% | — | +101.4% | +75.2% | >999% | — | <-999% | <-999% | <-999% |
Range-$3.29B – $5.23B
CAGR+832.6%
Avg YoY Growth>999%
Median YoY Growth-182.6%
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's cash provided by (used in) investing activity, including discontinued operation?
- Roivant Sciences (ROIV) reported cash provided by (used in) investing activity, including discontinued operation of -$1.09B in Q2 2025.
- How has Roivant Sciences's cash provided by (used in) investing activity, including discontinued operation changed year-over-year?
- Roivant Sciences's cash provided by (used in) investing activity, including discontinued operation decreased by 112409.4% year-over-year, from -$965.00K to -$1.09B.
- What does cash provided by (used in) investing activity, including discontinued operation mean?
- The total net cash flow from all investing activities, including both ongoing and discontinued operations.